These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5443510)

  • 1. Two-year follow-up study of measles vaccine antibodies.
    Med J Aust; 1970 Mar; 1(11):532-4. PubMed ID: 5443510
    [No Abstract]   [Full Text] [Related]  

  • 2. One-year follow-up study of measles vaccine antibodies.
    Med J Aust; 1968 Nov; 2(19):831-3. PubMed ID: 5728208
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of antigenicity of inactivated measles vaccine on guinea pigs.
    Drevo M; Mares I; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):389-96. PubMed ID: 5752126
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine.
    Brown P; Gajdusek DC; Tsai T
    Am J Epidemiol; 1969 Dec; 90(6):514-8. PubMed ID: 5362859
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the combined use of killed and live measles vaccines. IV. Fou years follow-up.
    Ueda S; Takahashi M; Hosai H; Yamanishi K; Okuno Y
    Biken J; 1969 Jun; 12(2):69-75. PubMed ID: 5346351
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of measles neutralizing and hemagglutination-inhibition antibody titers in individual sera.
    Fulginiti VA; Kempe CH
    Am J Epidemiol; 1965 Sep; 82(2):135-42. PubMed ID: 5828888
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on measles in Thailand. 3. Field trials on measles vaccine.
    Tuchinda P; Sangkawibha N; Ueda S; Okuno Y; Bukkavesa S
    Biken J; 1968 Dec; 11(4):251-9. PubMed ID: 5721531
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of 3 measles vaccines. II. Evaluation of antibody levels and serologic conversion after vaccination according to the results of hemagglutination-inhibition test].
    Przegl Epidemiol; 1969; 23(2):175-83. PubMed ID: 5803031
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reactions of immunoglobulins and specific antibodies in vaccinated and nonvaccinated children with measles (author's transl].
    Wiedermannová D; Wiedermann D; Bozdĕchová M; Pejćochová J
    Cas Lek Cesk; 1977 Feb; 116(7):205-9. PubMed ID: 851980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increase of immunoglobulins G, A, M, D and specific antibodies in a group of children vaccinated against measles by Czechoslovak live vaccine Movivac Sevac].
    Wiedermannová D; Wiedermann D; Bozdĕchová M; Hatiarová Z
    Cas Lek Cesk; 1973 Mar; 112(10):297-301. PubMed ID: 4691543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.